Ethically justified, clinically applicable criteria for physician decision-making in psychopharmacological enhancement
Neuroethics 2 (2):89-102 (2009)
|Abstract||Advances in psychopharmacology raise the prospects of enhancing neurocognitive functions of humans by improving attention, memory, or mood. While general ethical reflections on psychopharmacological enhancement have been increasingly published in the last years, ethical criteria characterizing physicians’ role in neurocognitive enhancement and guiding their decision-making still remain highly unclear. Here it will be argued that also in the medical domain the use of cognition-enhancing drugs is not intrinsically unethical and that, in fact, physicians should assume an important role in gating their usage. For finding normative orientation, concepts of disease, normality or medicine will not be helpful since—due to their cryptonormative nature—they rather hamper than allow targeted discussion and decision-making. As an alternative, the common and widely accepted bioethical criteria of beneficence, non-maleficence, autonomy and distributive justice allow a clinically applicable, highly differentiated context- and case-sensitive approach. By embedding decision-making in a participative physician–patient relationship extrinsic objections against neurocognitive enhancement (e.g. invalid perceptions about efficacy, benefit or risk; questionable voluntariness; restrained decision-making capacity) can be curtailed.|
|Keywords||Neuroenhancement Psychopharmacology Ethics Physician Drugs|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Rivka Grundstein-Amado (1991). An Integrative Model of Clinical-Ethical Decision Making. Theoretical Medicine and Bioethics 12 (2).
Harold Bursztajn (ed.) (1981/1990). Medical Choices, Medical Chances: How Patients, Families, and Physicians Can Cope with Uncertainty. Routledge.
Gretchen B. Chapman & Frank A. Sonnenberg (eds.) (2000). Decision Making in Health Care: Theory, Psychology, and Applications. Cambridge University Press.
Katherine Drabiak-Syed (2011). Reining In the Pharmacological Enhancement Train: We Should Remain Vigilant About Regulatory Standards for Prescribing Controlled Substances. Journal of Law, Medicine and Ethics 39 (2):272-279.
Maartje Schermer, Ineke Bolt, Reinoud de Jongh & Berend Olivier (2009). The Future of Psychopharmacological Enhancements: Expectations and Policies. Neuroethics 2 (2):75-87.
Douglas N. Walton (1985). Physician-Patient Decision-Making: A Study in Medical Ethics. Greenwood Press.
David Fritzsche & E. Oz (2007). Personal Values' Influence on the Ethical Dimension of Decision Making. Journal of Business Ethics 75 (4):335 - 343.
Greg Clarke, Robert T. Hall & Greg Rosencrance (2004). Physician-Patient Relations: No More Models. American Journal of Bioethics 4 (2):16 – 19.
Douglas N. Walton & Deborah C. Hobbs (1985). Non-Treatment of Spina Bifida Babies. Philosophy Research Archives 11:463-480.
Alan Schwartz (2008). Medical Decision Making: A Physician's Guide. Cambridge University Press.
Added to index2009-01-28
Total downloads31 ( #44,824 of 722,873 )
Recent downloads (6 months)1 ( #60,917 of 722,873 )
How can I increase my downloads?